Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Pregnancy in a kidney transplant patient treated with everolimus.

Carta P, Caroti L, Zanazzi M.

Am J Kidney Dis. 2012 Aug;60(2):329. doi: 10.1053/j.ajkd.2012.05.012. Review. No abstract available.

PMID:
22805522
[PubMed - indexed for MEDLINE]
2.

Pregnancy under everolimus-based immunosuppression.

Veroux M, Corona D, Veroux P.

Transpl Int. 2011 Dec;24(12):e115-7. doi: 10.1111/j.1432-2277.2011.01356.x. Epub 2011 Sep 22.

PMID:
21950359
[PubMed - indexed for MEDLINE]
3.

Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation.

Framarino dei Malatesta M, Corona LE, De Luca L, Rocca B, Manzia TM, Orlando G, Tisone G, Iaria G.

Transplantation. 2011 May 15;91(9):e69-71. doi: 10.1097/TP.0b013e3182154267. Review. No abstract available.

PMID:
21508801
[PubMed - indexed for MEDLINE]
4.

Everolimus (Certican) in combination with neoral in pediatric renal transplant recipients: interim analysis after 3 months.

Vester U, Kranz B, Wehr S, Boger R, Hoyer PF; RAD B 351 Study Group.

Transplant Proc. 2002 Sep;34(6):2209-10. No abstract available.

PMID:
12270366
[PubMed - indexed for MEDLINE]
5.

Experience with everolimus.

Augustine JJ, Hricik DE.

Transplant Proc. 2004 Mar;36(2 Suppl):500S-503S. Review.

PMID:
15041396
[PubMed - indexed for MEDLINE]
6.

Conversion of stable kidney transplant recipients from a twice-daily to once-daily everolimus regimen.

Carmellini M, Collini A, Ruggieri G, Bernini M.

Transplant Proc. 2010 May;42(4):1312-3. doi: 10.1016/j.transproceed.2010.03.098.

PMID:
20534288
[PubMed - indexed for MEDLINE]
7.

Everolimus versus azathioprine in a cyclosporine and ketoconazole-based immunosuppressive therapy in kidney transplant: 3-year follow-up of an open-label, prospective, cohort, comparative clinical trial.

Gonzalez F, Espinoza M, Herrera P, Rocca X, Reynolds E, Lorca E, Roessler E, Hidalgo J, Espinoza O.

Transplant Proc. 2010 Jan-Feb;42(1):270-2. doi: 10.1016/j.transproceed.2009.12.048.

PMID:
20172327
[PubMed - indexed for MEDLINE]
8.

Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression.

Iaria G, Pisani F, Iorio B, Lucchesi C, De Luca L, Ielpo B, D'Andria D, Tariciotti L, Tisone G.

Transplant Proc. 2006 May;38(4):1018-9.

PMID:
16757249
[PubMed - indexed for MEDLINE]
9.

[Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations].

Arns W, Budde K, Eitner F, Gwinner W, Hugo C, Pressmar K, Weimann A, Witzke O.

Dtsch Med Wochenschr. 2011 Dec;136(49):2554-9. doi: 10.1055/s-0031-1292822. Epub 2011 Nov 30. German. No abstract available.

PMID:
22131077
[PubMed - indexed for MEDLINE]
10.

Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?

Farsetti S, Zanazzi M, Caroti L, Rosso G, Larti A, Marcucci R, Fedi S, Rogolino A, Cellai AP, Abbate R, Bertoni E, Salvadori M.

Transplant Proc. 2010 May;42(4):1381-2. doi: 10.1016/j.transproceed.2010.03.112.

PMID:
20534308
[PubMed - indexed for MEDLINE]
11.

Conversion from sirolimus to everolimus in maintenance renal transplant recipients within a calcineurin inhibitor-free regimen: results of a 6-month pilot study.

Kamar N, Jaafar A, Esposito L, Ribes D, Durand D, Di-Giambattista F, Tack I, Rostaing L.

Clin Nephrol. 2008 Aug;70(2):118-25.

PMID:
18793527
[PubMed - indexed for MEDLINE]
12.

Pregnancy under sirolimus-based immunosuppression.

Guardia O, Rial Mdel C, Casadei D.

Transplantation. 2006 Feb 27;81(4):636. No abstract available.

PMID:
16495817
[PubMed - indexed for MEDLINE]
13.

Clinical experience with everolimus (Certican): optimizing dose and tolerability.

Pascual J, Marcén R, Ortuño J.

Transplantation. 2005 May 15;79(9 Suppl):S80-4.

PMID:
15880021
[PubMed - indexed for MEDLINE]
14.

Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients.

Ettenger RB, Grimm EM.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 2):S22-8. Review.

PMID:
11583941
[PubMed - indexed for MEDLINE]
15.

Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.

Coentrão L, Carvalho C, Sampaio S, Oliveira JG, Pestana MI.

Transplant Proc. 2010 Jun;42(5):1867-9. doi: 10.1016/j.transproceed.2010.01.059.

PMID:
20620539
[PubMed - indexed for MEDLINE]
16.

Clinical experience with everolimus (Certican): a summary.

Ponticelli C.

Transplantation. 2005 May 15;79(9 Suppl):S93-4. No abstract available.

PMID:
15880024
[PubMed - indexed for MEDLINE]
17.

Once daily everolimus is safe and effective in de novo renal transplant recipients: six-month results of a pilot study.

Favi E, Spagnoletti G, Gargiulo A, Salerno MP, Romagnoli J, Citterio F.

Transplant Proc. 2010 May;42(4):1308-11. doi: 10.1016/j.transproceed.2010.03.099.

PMID:
20534287
[PubMed - indexed for MEDLINE]
18.

Reduction in calcineurin inhibitor exposure and maintenance of effective immunosuppression: clinical experience with everolimus (Certican).

Monaco AP, Morris PJ.

Transplantation. 2005 May 15;79(9 Suppl):S67-8. No abstract available.

PMID:
15880017
[PubMed - indexed for MEDLINE]
19.

Once-a-day administration of everolimus, cyclosporine, and steroid after renal transplantation: a review of the rationale.

Corbetta G, Ponticelli C.

Transplant Proc. 2010 May;42(4):1303-7. doi: 10.1016/j.transproceed.2010.03.084.

PMID:
20534286
[PubMed - indexed for MEDLINE]
20.

Everolimus in clinical practice--renal transplantation.

Pascual J.

Nephrol Dial Transplant. 2006 Jul;21 Suppl 3:iii18-23. Review.

PMID:
16815852
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk